Patents by Inventor Jeong-Yeon MUN

Jeong-Yeon MUN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL BIOMARKER FOR DIAGNOSING AND PREDICTING METASTASIS OR PROGNOSIS OF VARIOUS CANCERS, AND USE
    Publication number: 20240301503
    Abstract: The present invention relates to a novel biomarker for diagnosing cancer, and a use thereof. STC1, a novel biomarker for diagnosing or predicting the prognosis of cancer according to the present invention, was found to be related to poor prognosis of cancer patients according to the expression level, and was found to be overexpressed in various cancer cell lines. In addition, STC1 was found to be a biomarker related to the proliferation, invasion, and migration (metastasis) of cancer cells. In addition, it was found that STC1 is detected in the serum or urine of bladder cancer patients, and can be effectively used for diagnosing and predicting the prognosis of bladder cancer by identifying differences in expression according to the patient's clinical stage.
    Type: Application
    Filed: June 22, 2022
    Publication date: September 12, 2024
    Applicant: Dong-A University Research Foundation for Industry-Academy Cooperation
    Inventors: Sun-Hee LEEM, Jeong-Yeon MUN, Mi-So JEONG, Min-Hye KIM, Gi-Eun YANG